Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

440 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Docetaxel versus abiraterone for metastatic hormone-sensitive prostate cancer with focus on efficacy of sequential therapy.
Yanagisawa T, Hata K, Narita S, Hatakeyama S, Mori K, Yata Y, Sano T, Otsuka T, Hara S, Miyajima K, Enei Y, Fukuokaya W, Nakazono M, Matsukawa A, Miki J, Habuchi T, Ohyama C, Shariat SF, Kimura T. Yanagisawa T, et al. Among authors: miyajima k. Prostate. 2023 May;83(6):563-571. doi: 10.1002/pros.24488. Epub 2023 Jan 20. Prostate. 2023. PMID: 36661102
Abiraterone acetate versus nonsteroidal antiandrogen with androgen deprivation therapy for high-risk metastatic hormone-sensitive prostate cancer.
Yanagisawa T, Kimura T, Mori K, Suzuki H, Sano T, Otsuka T, Iwamoto Y, Fukuokaya W, Miyajima K, Enei Y, Sakanaka K, Matsukawa A, Onuma H, Obayashi K, Tsuzuki S, Hata K, Shimomura T, Miki J, Egawa S. Yanagisawa T, et al. Among authors: miyajima k. Prostate. 2022 Jan;82(1):3-12. doi: 10.1002/pros.24243. Epub 2021 Sep 24. Prostate. 2022. PMID: 34559410
Percutaneous cryoablation versus partial nephrectomy for cT1b renal tumors: An inverse probability weight analysis.
Aikawa K, Yanagisawa T, Fukuokaya W, Shimizu K, Miyajima K, Nakazono M, Iwatani K, Matsukawa A, Obayashi K, Kimura S, Tsuzuki S, Sasaki H, Abe H, Sadaoka S, Miki J, Kimura T. Aikawa K, et al. Among authors: miyajima k. Urol Oncol. 2023 Mar;41(3):150.e11-150.e19. doi: 10.1016/j.urolonc.2022.11.025. Epub 2023 Jan 4. Urol Oncol. 2023. PMID: 36604229
Treatment Results of High-dose-rate Brachytherapy and External Beam Radiation With Long-term Androgen Deprivation Therapy for Patients With Metastatic Prostate Cancer.
Suzuki H, Urabe F, Iwatani K, Miyajima K, Imai YU, Tashiro K, Tsuzuki S, Honda M, Koike Y, Aoki M, Sato S, Takahashi H, Miki K, Kimura T. Suzuki H, et al. Among authors: miyajima k. Anticancer Res. 2023 Jul;43(7):3135-3143. doi: 10.21873/anticanres.16486. Anticancer Res. 2023. PMID: 37352008
Clinical characteristics of secondary bladder cancer developing after low-/high-dose-rate brachytherapy to treat localized prostate cancer.
Miyajima K, Suzuki H, Urabe F, Iwatani K, Imai Y, Yasue K, Yanagisawa T, Kimura S, Tashiro K, Tsuzuki S, Koike Y, Miki J, Yuen S, Sasaki T, Aoki M, Sato S, Takahashi H, Miki K, Kimura T. Miyajima K, et al. Int J Clin Oncol. 2023 Sep;28(9):1200-1206. doi: 10.1007/s10147-023-02383-1. Epub 2023 Jul 11. Int J Clin Oncol. 2023. PMID: 37432614
Comparison of neoadjuvant and adjuvant chemotherapy for upper tract urothelial carcinoma in real-world practice: a multicenter retrospective study.
Takahashi K, Urabe F, Suhara Y, Nakano J, Yoshihara K, Goto Y, Sadakane I, Koike Y, Yata Y, Suzuki H, Kurawaki S, Miyajima K, Iwatani K, Imai Y, Sakanaka K, Nakazono M, Kurauchi T, Kayano S, Onuma H, Aikawa K, Yanagisawa T, Tashiro K, Tsuzuki S, Koike Y, Furuta A, Miki J, Kimura T. Takahashi K, et al. Among authors: miyajima k. Jpn J Clin Oncol. 2023 Dec 7;53(12):1208-1214. doi: 10.1093/jjco/hyad118. Jpn J Clin Oncol. 2023. PMID: 37647644
Presurgical immune-oncology/tyrosine kinase inhibitor combination therapy for renal cell carcinoma with a vena cava tumor thrombus: a single-institution case series.
Urabe F, Iwatani K, Hashimoto M, Suzuki H, Miyajima K, Murakami M, Tashiro K, Tsuzuki S, Furuta A, Sato S, Takahashi H, Kimura T. Urabe F, et al. Among authors: miyajima k. Transl Androl Urol. 2023 Aug 31;12(8):1321-1325. doi: 10.21037/tau-23-203. Epub 2023 Aug 10. Transl Androl Urol. 2023. PMID: 37680224 Free PMC article.
Real-world outcomes of adjuvant immunotherapy candidates with upper tract urothelial carcinoma: results of a multicenter cohort study.
Kagawa H, Urabe F, Kiuchi Y, Katsumi K, Yamaguchi R, Suhara Y, Yoshihara K, Goto Y, Sadakane I, Yata Y, Saito S, Kurawaki S, Ajisaka S, Miyajima K, Takahashi K, Iwatani K, Imai Y, Sakanaka K, Nakazono M, Kurauchi T, Kayano S, Onuma H, Aikawa K, Yanagisawa T, Tashiro K, Tsuzuki S, Furuta A, Miki J, Kimura T; JIKEI-YAYOI Collaborative Group. Kagawa H, et al. Among authors: miyajima k. Int J Clin Oncol. 2024 Jan;29(1):55-63. doi: 10.1007/s10147-023-02424-9. Epub 2023 Oct 21. Int J Clin Oncol. 2024. PMID: 37863996
Novel technique for cognitive magnetic resonance imaging-transperineal ultrasound fusion transperineal prostate biopsy with injection of bubbled jelly into urethra after abdominoperineal excision.
Miyajima K, Urabe F, Nakano J, Iwatani K, Tashiro K, Tsuzuki S, Sato S, Takahashi H, Kimura T, Miki K. Miyajima K, et al. IJU Case Rep. 2023 Aug 14;6(6):365-369. doi: 10.1002/iju5.12624. eCollection 2023 Nov. IJU Case Rep. 2023. PMID: 37928278 Free PMC article.
440 results